Skip to main content

Table 1 Measures of secondary hyperalgesia and weight bearing

From: Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis

Treatment

Baseline

Day 1

Day 3

Day 7

Day 14

Day 21

Weight bearing [% on inflamed hindlimb]

Saline i.p.

49.7 ± 0.7

23.5 ± 3.1

27.0 ± 1.1

31.6 ± 2.4

40.0 ± 2.6

50.3 ± 2.1

Sgp130 i.p.

49.8 ± 0.6

27.0 ± 2.6

25.3 ± 2.5

26.1 ± 3.3

40.8 ± 2.5

46.4 ± 1.7

Saline i.a.

51.1 ± 0.6

30.6 ± 3.8

30.3 ± 1.5

33.6 ± 2.8

39.2 ± 2.4

45.5 ± 1.0

Sgp130 i.a.

50.6 ± 0.8

32.4 ± 0.8 *

38.0 ± 1.7+,**

43.2 ± 1.3 +,**

44.2 ± 1.2

48.4 ± 2.5

Mechanical thresholds paw [g]

Saline i.p.

26.2 ± 2.9

16.6 ± 1.7

12.5 ± 1.5

12.2 ± 1.3

12.3 ± 1.0

14.6 ± 1.9

Sgp130 i.p.

24.6 ± 3.0

14.2 ± 2.4

16.7 ± 1.9

14.0 ± 1.1

12.3 ± 1.8

13.3 ± 1.7

Saline i.a.

22.9 ± 2.1

14.5 ± 3.7

12.8 ± 1.8

9.8 ± 2.6

9.0 ± 2.4

12.3 ± 2.4

sgp130 i.a.

24.4 ± 1.6

15.5 ± 2.0

14.5 ± 2.2

12.7 ± 1.8

15.1 ± 2.6

14.7 ± 2.1

Thermal withdrawal thresholds paw [s]

Saline i.p.

15.3 ± 0.8

10.3 ± 0.9

10.3 ± 0.9

8.7 ± 0.8

8.4 ± 0.9

9.3 ± 0.9

sgp130 i.p.

14.9 ± 0.7

10.2 ± 0.8

11.3 ± 1.4

8.2 ± 1.3

9.4 ± 1.0

10.2 ± 0.9

Saline i.a.

14.9 ± 0.6

9.8 ± 0.8

9.5 ± 0.8

9.3 ± 1.1

10.1 ± 0.9

10.3 ± 1.3

sgp130 i.a.

13.4 ± 0.7

9.4 ± 0.7

10.7 ± 0.8

10.0 ± 0.7

10.5 ± 1.2

12.4 ± 1.0

  1. Sgp, soluble glycoprotein 130; i.a., intra-articular; i.p., intra-peritoneal; data are presented as mean ± SEM. * differences between sgp130 i.p. and and sgp130 i.a.; + differences between sgp130 i.a. and saline i.a.; one symbol P < 0.05; two symbols P < 0.01.